Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer have?
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer has 2,866 citations in the OpenAlex counts ScholarIQ stores.
When was Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer published?
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer has 2019 year in the ScholarIQ index.
What is the open-access status of Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer?
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer?
The DOI for Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer is on the source record.
What is the PMID of Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer?
The PMID for Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer is on the source record.
What is the OpenAlex record for Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer?
The OpenAlex for Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer is on the source record.